Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 221
interventional 133
Observational 81
Registry 7

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 57
Drug|placebo 15
Device 13
Other 10
Biological 6
Procedure 6
Biological|Drug 5
Behavioral 4
Biological|Drug|Other 2
Biological|placebo 2
Dietary Supplement|placebo 2
Other|Procedure 2
Behavioral|Drug 1
Biological|Drug|Procedure 1
Combination Product 1
Device|Drug|Other|placebo 1
Device|placebo 1
Diagnostic Test 1
Dietary Supplement 1
Drug|Other 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 35
China 13
France 9
NA 8
Italy 5
Canada 4
Germany 4
Spain 4
Belgium 3
Denmark 3
Hong Kong 3
Tanzania 3
Australia 2
India 2
Ireland 2
Kenya 2
Korea, Republic of 2
Taiwan 2
United States|Canada 2
United States|Puerto Rico 2
Argentina|Brazil|Peru 1
Brazil 1
Czech Republic|France|Germany|Hungary|Italy|Lithuania|Poland|Portugal|Serbia|Sweden|Switzerland|Turkey 1
Finland 1
France|Germany|Greece|Italy|Netherlands|Spain 1
France|Germany|Italy|Portugal|Spain|Sweden|United Kingdom 1
Ghana 1
Latvia 1
Mexico 1
Norway 1
Sweden 1
Switzerland 1
Thailand 1
Tunisia 1
United States|Argentina|Austria|Belgium|France|Germany|Spain|United Kingdom 1
United States|Australia|Canada|Colombia|France|Hungary|Israel|Italy|Japan|Korea, Republic of|Puerto Rico|Russian Federation|Spain|United Kingdom 1
United States|Austria|Belgium|Canada|France|Germany|Ireland|Israel|Italy|Netherlands|Spain|Sweden|United Kingdom 1
United States|Belgium|Bulgaria|Hungary|Poland|Romania|Russian Federation|Ukraine 1
United States|Brazil|Bulgaria|Canada|China|Czech Republic|France|Hungary|Italy|Korea, Republic of|Latvia|Lithuania|Netherlands|Poland|Romania|Slovakia|South Africa|Taiwan|Thailand|Ukraine 1
United States|Brazil|Mexico 1
United States|Czechia|France|Germany|Hungary|Israel|Italy|Spain|United Kingdom 1
United States|Germany|Puerto Rico 1
United States|Puerto Rico|Tanzania 1

Sites per Study

Site_count Study_Count
1 77
2 7
3 6
4 3
5 4
6 3
7 4
8 3
9 3
13 3
15 2
16 1
17 1
18 1
28 1
30 1
33 1
35 1
36 1
38 2
41 1
45 1
72 1
76 1
79 1
108 1
155 1
180 1

Phase

Phase Study_Count
Phase 2 47
N/A 39
Phase 3 18
Phase 4 15
Phase 1 10
Phase 2/Phase 3 2
Early Phase 1 1
Phase 1/Phase 2 1

Number of Arms

Number_of_Arms Count_of_Studies
1 46
2 65
3 16
4 1
6 1
NA 4

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 22 15.0000 9.00 38 1.00000 147.00 20.0000 22.0
1st Qu. 22 82.5000 21.25 38 39.00000 155.75 134.5000 55.5
Median 22 119.0000 43.00 38 58.00000 164.50 357.5000 100.0
Mean 22 378.8205 40.50 38 90.12766 164.50 614.9444 234.0
3rd Qu. 22 282.5000 44.75 38 126.50000 173.25 505.7500 407.5
Max. 22 6582.0000 90.00 38 396.00000 182.00 4012.0000 700.0

Trial Group Type

group_type Group_Count
Experimental 127
Active Comparator 55
Placebo Comparator 23
No Intervention 16
Other 9
Sham Comparator 4
NA 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 77
Single Group Assignment 47
Crossover Assignment 3
Factorial Assignment 2
Sequential Assignment 2
NA 2

Primary Purpose

primary_purpose Study_Count
Treatment 102
Prevention 12
Other 8
Diagnostic 7
Health Services Research 2
Supportive Care 2

Observational Studies

Studies by Country

Country Study_Count
United States 26
China 5
Denmark 5
NA 4
United Kingdom 4
Canada 3
Italy 3
Japan 3
Switzerland 3
Germany 2
Korea, Republic of 2
Netherlands 2
Spain 2
Taiwan 2
United States|Canada 2
Austria 1
Austria|Germany 1
Belgium 1
Egypt 1
France 1
Greece 1
Hungary 1
Ireland 1
Kenya 1
Norway 1
Turkey 1
United States|Argentina|Brazil|Canada|China|Germany|India|Israel|Italy|Japan|Korea, Republic of|Mexico|Puerto Rico|Russian Federation|Saudi Arabia|Spain|Turkey|United Arab Emirates|United Kingdom 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 63
2 3
3 3
5 1
6 1
7 1
9 1
10 2
14 1
27 1
28 1
51 1
64 1
153 1

Enrollment Metrics

Measure Observational
Min 3.0000
1st Qu 80.0000
Median 179.0000
Mean 505.9383
3rd Qu 445.0000
Max 5000.0000

Observation Model

observational_model Study_Count
Cohort 57
Case-Control 8
Case-Only 7
Other 4
Case Control 2
Case Control, Natural History 1
Family-Based 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 61
Retrospective 11
Other 4
Cross-Sectional 3
Longitudinal, Retrospective/Prospective 1
NA 1

Registries

Studies by Country

Country Study_Count
Egypt 1
France 1
Italy 1
Mexico 1
Spain 1
Thailand 1
United States 1

Sites per Study

Site_count Study_Count
1 5
2 1
7 1

Enrollment Metrics

Measure Registries
Min 100.000
1st Qu 279.000
Median 550.000
Mean 7601.143
3rd Qu 1000.000
Max 50000.000

Registry Model

observational_model Study_Count
Cohort 6
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 5
Other 2

Follow-up

target_duration Study_Count
5 Years 2
1 Month 1
1 Year 1
12 Months 1
2 Years 1
3 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04364763 A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) https://ClinicalTrials.gov/show/NCT04364763 Recruiting Renibus Therapeutics, Inc. 2021-06-30
NCT04288856 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS) https://ClinicalTrials.gov/show/NCT04288856 Enrolling by invitation Biogen 2023-07-19
NCT03312738 A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor https://ClinicalTrials.gov/show/NCT03312738 Active, not recruiting Novartis 2020-05-19
NCT03205956 Measuring Parkinson’s Disease Progression https://ClinicalTrials.gov/show/NCT03205956 Completed Washington University School of Medicine 2019-10-18
NCT03202914 Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression https://ClinicalTrials.gov/show/NCT03202914 Completed Johns Hopkins Bloomberg School of Public Health 1993-05-31
NCT03192579 Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial https://ClinicalTrials.gov/show/NCT03192579 Completed Kobe University 2017-06-02
NCT03174912 In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? https://ClinicalTrials.gov/show/NCT03174912 Completed Ankara Training and Research Hospital 2016-12-31
NCT03154190 Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer https://ClinicalTrials.gov/show/NCT03154190 Recruiting Stanford University 2020-11-30
NCT03150602 A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy https://ClinicalTrials.gov/show/NCT03150602 Recruiting Taiwan Mundipharma Pharmaceuticals Ltd. 2020-12-31
NCT03086512 A Study Comparing Computerized Tomographic Progression of Bone Bridging After Subtalar Fusion Using Fully and Partially Threaded Screws https://ClinicalTrials.gov/show/NCT03086512 Recruiting St. Paul’s Hospital, Canada 2022-04-30
NCT03014869 High Flow Nasal Cannula vs NPPV in Moderate Chronic Obstructive Pulmonary Disease Exacerbation https://ClinicalTrials.gov/show/NCT03014869 Recruiting China-Japan Friendship Hospital 2020-12-31
NCT03003559 HFNC vs Nasal Cannula in Mild Chronic Obstructive Pulmonary Disease Exacerbation https://ClinicalTrials.gov/show/NCT03003559 Recruiting China-Japan Friendship Hospital 2020-12-31
NCT02959749 Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02959749 Completed Qingdao Central Hospital 2017-10-31
NCT02937597 E-learning Proficiency Based Progression Training Programme for Clinical Communication on ISBAR Performance (eISBAR) https://ClinicalTrials.gov/show/NCT02937597 Completed University College Cork 2018-04-30
NCT02886754 Proficiency-Based Progression Training for Clinical Communication https://ClinicalTrials.gov/show/NCT02886754 Completed University College Cork 2016-09-16
NCT02863718 Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression https://ClinicalTrials.gov/show/NCT02863718 Active, not recruiting German CLL Study Group 2019-03-07
NCT02816645 One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson’s Disease Progression? https://ClinicalTrials.gov/show/NCT02816645 Recruiting University Hospital, Clermont-Ferrand 2020-06-30
NCT02789020 Image Parkinson’s Disease Progression Study https://ClinicalTrials.gov/show/NCT02789020 Active, not recruiting University of Florida 2020-12-31
NCT02744976 Coronary Artery Disease Progression in Patients With Prediabetes https://ClinicalTrials.gov/show/NCT02744976 Recruiting Pauls Stradins Clinical University Hospital 2018-12-31
NCT02681809 A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR https://ClinicalTrials.gov/show/NCT02681809 Completed Oxurion 2019-11-18
NCT02661191 Vitamin D Deficiency and Asthma Exacerbation https://ClinicalTrials.gov/show/NCT02661191 Completed University of Turin, Italy 2013-03-31
NCT02643875 Investigation of the Effect of Short-term Orthokeratology With Increased Compression Factor on Ocular Parameters https://ClinicalTrials.gov/show/NCT02643875 Completed The Hong Kong Polytechnic University 2016-11-18
NCT02643342 A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye https://ClinicalTrials.gov/show/NCT02643342 Active, not recruiting The Hong Kong Polytechnic University 2020-03-31
NCT02036060 Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer. https://ClinicalTrials.gov/show/NCT02036060 Active, not recruiting Spanish Oncology Genito-Urinary Group 2020-04-30
NCT02481648 Feasibility of Measuring Exercise’s Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer https://ClinicalTrials.gov/show/NCT02481648 Active, not recruiting Vancouver Prostate Centre 2018-12-31
NCT02431702 A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant’s With Recent-onset Schizophrenia or Schizophreniform https://ClinicalTrials.gov/show/NCT02431702 Completed Janssen Scientific Affairs, LLC 2019-11-12
NCT02386735 Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD https://ClinicalTrials.gov/show/NCT02386735 Recruiting Cantonal Hosptal, Baselland 2020-09-30
NCT02371564 High Flow Oxygen Therapy in Patients Suffering From Chronic Obstructive Pulmonary Disease Exacerbation: Effects and Mechanisms of Action https://ClinicalTrials.gov/show/NCT02371564 Recruiting University Hospital, Angers 2019-12-31
NCT02312557 Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide https://ClinicalTrials.gov/show/NCT02312557 Active, not recruiting OHSU Knight Cancer Institute 2021-01-01
NCT02305927 Trial of Vitamin D in HIV Progression, Birth Outcomes, and Child Health https://ClinicalTrials.gov/show/NCT02305927 Completed Harvard School of Public Health 2019-09-18
NCT02234440 Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance https://ClinicalTrials.gov/show/NCT02234440 Completed Institute of Liver and Biliary Sciences, India 2015-12-31
NCT02221427 The Labour Progression Study, a Cluster Randomised Trial on Labour Progression for First Time Mothers https://ClinicalTrials.gov/show/NCT02221427 Active, not recruiting Ostfold Hospital Trust 2017-03-31
NCT02206503 Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM) https://ClinicalTrials.gov/show/NCT02206503 Completed Fondazione Neoplasie Sangue Onlus 2015-04-30
NCT02186184 Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial https://ClinicalTrials.gov/show/NCT02186184 Completed Beijing Tongren Hospital 2017-06-30
NCT02176018 Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine https://ClinicalTrials.gov/show/NCT02176018 Completed Cady, Roger, M.D. 2017-02-28
NCT02130167 Low Concentration Atropine for Myopia Progression in School Children https://ClinicalTrials.gov/show/NCT02130167 Completed Chang Gung Memorial Hospital 2017-07-31
NCT02113800 Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study https://ClinicalTrials.gov/show/NCT02113800 Recruiting AIO-Studien-gGmbH 2019-09-30
NCT02064491 Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC https://ClinicalTrials.gov/show/NCT02064491 Completed Finnish Lung Cancer Group 2016-12-31
NCT01300546 Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine https://ClinicalTrials.gov/show/NCT01300546 Completed Cady, Roger, M.D. 2012-04-30
NCT01299948 Progression of HIV-Disease Under Low Dose Corticosteroids https://ClinicalTrials.gov/show/NCT01299948 Completed Medical Mission Institute, Germany 2011-03-31
NCT02016365 Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis https://ClinicalTrials.gov/show/NCT02016365 Completed Umeå University 2014-12-31
NCT03242915 Pembrolizumab in Combination With Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Targetable Genetic Alterations, Previously Treated With Appropriate Targeted Agents, With Progressive Disease https://ClinicalTrials.gov/show/NCT03242915 Recruiting University of Michigan Rogel Cancer Center 2021-08-31
NCT01978951 Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of Thailand https://ClinicalTrials.gov/show/NCT01978951 Completed Bhumirajanagarindra Kidney Institute, Thailand 2013-07-31
NCT01944033 β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation https://ClinicalTrials.gov/show/NCT01944033 Completed University of Monastir 2016-07-31
NCT01899586 Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly https://ClinicalTrials.gov/show/NCT01899586 Completed Duke University 2011-11-30
NCT01881620 PET Enhanced CT Scan Performance in Cancer https://ClinicalTrials.gov/show/NCT01881620 Completed Institut Bergonié 2012-07-19
NCT01840592 Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib https://ClinicalTrials.gov/show/NCT01840592 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-04-30
NCT04400058 Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression https://ClinicalTrials.gov/show/NCT04400058 Recruiting Octapharma 2020-12-30
NCT01737450 Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive https://ClinicalTrials.gov/show/NCT01737450 Completed Centre Leon Berard 2018-09-30
NCT01684761 Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis https://ClinicalTrials.gov/show/NCT01684761 Completed Opexa Therapeutics, Inc. 2016-10-31
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT01656278 Completed King Christian X´Hospital for Rheumatic Diseases 2017-05-31
NCT01591590 Correlating the Tumoral Metabolic Progression Index to Patient’s Outcome in Advanced Colorectal Cancer https://ClinicalTrials.gov/show/NCT01591590 Active, not recruiting Jules Bordet Institute 2019-06-30
NCT01556100 Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson’s Disease Progression https://ClinicalTrials.gov/show/NCT01556100 Completed Chang Gung Memorial Hospital 2015-05-31
NCT01480986 IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC https://ClinicalTrials.gov/show/NCT01480986 Completed Peking University 2012-09-30
NCT01453257 Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients https://ClinicalTrials.gov/show/NCT01453257 Completed Grupo Hospital de Madrid 2011-10-31
NCT01437488 Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy https://ClinicalTrials.gov/show/NCT01437488 Completed Thomas Jefferson University 2014-08-04
NCT01425957 Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment https://ClinicalTrials.gov/show/NCT01425957 Completed Qualissima 2015-08-31
NCT01425112 Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to Trabeculectomy https://ClinicalTrials.gov/show/NCT01425112 Completed Sudhalkar Eye Hospital 2011-05-31
NCT01425073 Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya https://ClinicalTrials.gov/show/NCT01425073 Completed University of Washington 2013-10-31
NCT01350882 Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation https://ClinicalTrials.gov/show/NCT01350882 Completed University Hospital, Tours 2012-10-31
NCT01328951 A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy https://ClinicalTrials.gov/show/NCT01328951 Completed Hoffmann-La Roche 2015-12-31
NCT04436120 Treatment Resistance Following Anti-cancer Therapies https://ClinicalTrials.gov/show/NCT04436120 Recruiting Pfizer 2020-12-30
NCT04429867 Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease https://ClinicalTrials.gov/show/NCT04429867 Active, not recruiting WellStar Health System 2020-12-07
NCT04374526 Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. https://ClinicalTrials.gov/show/NCT04374526 Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2020-09-30
NCT04371510 Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients https://ClinicalTrials.gov/show/NCT04371510 Recruiting Centre Hospitalier Universitaire de Nice 2020-10-22
NCT04369456 Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients https://ClinicalTrials.gov/show/NCT04369456 Recruiting Centre Hospitalier Universitaire de Nice 2020-10-22
NCT04313023 The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04313023 Recruiting Pulmotect, Inc. 2020-09-30
NCT04295707 Monthly Replacement Orthokeratology for Myopia Control in Existing Lens Wearers https://ClinicalTrials.gov/show/NCT04295707 Recruiting The Hong Kong Polytechnic University 2022-09-30
NCT04274933 A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy https://ClinicalTrials.gov/show/NCT04274933 Recruiting AbbVie 2021-03-28
NCT04245397 SX-682 Treatment in Subjects With Myelodysplastic Syndrome Who Had Disease Progression or Are Intolerant to Prior Therapy https://ClinicalTrials.gov/show/NCT04245397 Recruiting Syntrix Biosystems, Inc. 2022-05-31
NCT04223050 Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation https://ClinicalTrials.gov/show/NCT04223050 Recruiting Sydvestjysk Hospital 2020-07-30
NCT04205838 Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma https://ClinicalTrials.gov/show/NCT04205838 Recruiting Jonsson Comprehensive Cancer Center 2021-12-01
NCT04150575 A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy https://ClinicalTrials.gov/show/NCT04150575 Recruiting Shanghai Henlius Biotech 2021-06-15
NCT04131634 Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer https://ClinicalTrials.gov/show/NCT04131634 Recruiting University of Texas Southwestern Medical Center 2021-12-16
NCT04131491 Epilepsy in Alzheimer’s Disease: Effect on Disease Progression https://ClinicalTrials.gov/show/NCT04131491 Recruiting Universitair Ziekenhuis Brussel 2023-09-30
NCT04098406 Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS) https://ClinicalTrials.gov/show/NCT04098406 Recruiting Clene Nanomedicine 2021-04-30
NCT04072601 Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT04072601 Recruiting Copenhagen University Hospital, Hvidovre 2022-12-31
NCT04033432 sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer https://ClinicalTrials.gov/show/NCT04033432 Recruiting Northwestern University 2021-06-03
NCT04017650 Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer https://ClinicalTrials.gov/show/NCT04017650 Recruiting M.D. Anderson Cancer Center 2024-06-30
NCT04007744 Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT04007744 Recruiting Mayo Clinic 2021-07-31
NCT03992456 Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer https://ClinicalTrials.gov/show/NCT03992456 Recruiting Academic and Community Cancer Research United 2021-08-07
NCT03990571 Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma https://ClinicalTrials.gov/show/NCT03990571 Recruiting M.D. Anderson Cancer Center 2022-12-30
NCT03973112 A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients With Disease Progression or Intolerant Toxicity After Standard Treatment https://ClinicalTrials.gov/show/NCT03973112 Recruiting Shanghai Henlius Biotech 2021-12-15
NCT03949101 Atropine for Children and Adolescent Myopia Progression Study https://ClinicalTrials.gov/show/NCT03949101 Enrolling by invitation Shanghai Eye Disease Prevention and Treatment Center 2021-05-08
NCT03943459 Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease https://ClinicalTrials.gov/show/NCT03943459 Recruiting InCor Heart Institute 2022-04-30
NCT03887741 Plasmapheresis Versus Plasma Infusion From Young APOE3 Homozygotes Into MCI APOE4 Homozygotes to Slow Disease Progression https://ClinicalTrials.gov/show/NCT03887741 Enrolling by invitation Mayo Clinic 2021-12-31
NCT03862807 Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant https://ClinicalTrials.gov/show/NCT03862807 Active, not recruiting Alnylam Pharmaceuticals 2021-01-31
NCT03703050 Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+ Anaplastic Large Cell Lymphoma, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2) https://ClinicalTrials.gov/show/NCT03703050 Recruiting Gustave Roussy, Cancer Campus, Grand Paris 2024-01-31
NCT03652298 Effects of a Neuroscience-based Technique on Post-traumatic Stress Disorder Symptoms, Inflammation, and Survival in Cancer Patients Announced of a Palliative Disease Progression and Their Partners https://ClinicalTrials.gov/show/NCT03652298 Recruiting Centre Oscar Lambret 2020-05-25
NCT03625466 A Study to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del https://ClinicalTrials.gov/show/NCT03625466 Active, not recruiting Vertex Pharmaceuticals Incorporated 2020-11-30
NCT03617757 Progression From Impaired Fasting Glucose to Diabetes Mellitus Among Chinese https://ClinicalTrials.gov/show/NCT03617757 Completed The University of Hong Kong 2019-01-22
NCT03601624 Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans https://ClinicalTrials.gov/show/NCT03601624 Recruiting Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado 2018-12-31
NCT03594656 Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson’s Disease https://ClinicalTrials.gov/show/NCT03594656 Recruiting Xuanwu Hospital, Beijing 2019-06-30
NCT03586661 Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer https://ClinicalTrials.gov/show/NCT03586661 Recruiting M.D. Anderson Cancer Center 2021-04-30
NCT03582488 Longitudinal Imaging Biomarkers of Disease Progression in DLB https://ClinicalTrials.gov/show/NCT03582488 Enrolling by invitation Mayo Clinic 2023-06-25
NCT03546426 Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies https://ClinicalTrials.gov/show/NCT03546426 Recruiting Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori 2021-01-31
NCT03514901 To Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progression With First-line+Vemurafenib+Cobimetinib. https://ClinicalTrials.gov/show/NCT03514901 Recruiting Intergruppo Melanoma Italiano 2021-04-03
NCT03513666 A Study of Toripalimab+ Pemetrexed Plus Carboplatin in Patients With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment https://ClinicalTrials.gov/show/NCT03513666 Active, not recruiting Shanghai Junshi Bioscience Co., Ltd. 2019-10-22
NCT03492450 Unraveling Early Walking Dysfunction in Non-disabled MS People: Assessment and Potential Therapeutic Interventions https://ClinicalTrials.gov/show/NCT03492450 Recruiting Fondazione Don Carlo Gnocchi Onlus 2019-12-31
NCT03469804 Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi’s Sarcoma https://ClinicalTrials.gov/show/NCT03469804 Recruiting Assistance Publique - Hôpitaux de Paris 2020-03-20
NCT01238172 Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance https://ClinicalTrials.gov/show/NCT01238172 Completed Alliance for Clinical Trials in Oncology 2017-11-18
NCT01230710 A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression https://ClinicalTrials.gov/show/NCT01230710 Completed Hoffmann-La Roche 2013-09-30
NCT01174368 Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T https://ClinicalTrials.gov/show/NCT01174368 Completed The Rogosin Institute 2016-12-31
NCT01111461 Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression https://ClinicalTrials.gov/show/NCT01111461 Completed Eisai Inc. 2012-05-31
NCT01077739 A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin https://ClinicalTrials.gov/show/NCT01077739 Completed Hoffmann-La Roche 2012-01-31
NCT01050322 Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment. https://ClinicalTrials.gov/show/NCT01050322 Completed Latin American Cooperative Oncology Group 2010-12-31
NCT00993499 Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib https://ClinicalTrials.gov/show/NCT00993499 Completed Boehringer Ingelheim 2014-09-30
NCT00944918 Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI) https://ClinicalTrials.gov/show/NCT00944918 Completed AstraZeneca 2011-06-30
NCT00943670 Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in Patients With Early Disease Progression https://ClinicalTrials.gov/show/NCT00943670 Completed Genentech, Inc. 2010-12-31
NCT00860431 Kremezin Study Against Renal Disease Progression in Korea https://ClinicalTrials.gov/show/NCT00860431 Completed Seoul National University Hospital 2013-09-30
NCT04343794 Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 https://ClinicalTrials.gov/show/NCT04343794 Recruiting The University of Hong Kong 2021-12-31
NCT04005144 Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04005144 Recruiting University of California, San Francisco 2022-08-01
NCT03753334 Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer. https://ClinicalTrials.gov/show/NCT03753334 Active, not recruiting CHU de Quebec-Universite Laval 2020-12-31
NCT03976375 Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008) https://ClinicalTrials.gov/show/NCT03976375 Recruiting Merck Sharp & Dohme Corp. 2023-08-21
NCT02499068 Madrid Project on the Management of Chronic Obstructive Pulmonary Disease With Home Telemonitoring https://ClinicalTrials.gov/show/NCT02499068 Completed Fundación Teófilo Hernando, Spain 2016-06-01
NCT00800800 Effects of Rosuvastatin on Aortic Stenosis Progression https://ClinicalTrials.gov/show/NCT00800800 Completed AstraZeneca 2008-09-30
NCT00707369 Adjunctive Antimicrobial Therapy of Periodontitis: Long-Term Effects on Disease Progression and Oral Microbiological Colonization https://ClinicalTrials.gov/show/NCT00707369 Completed University Hospital Muenster 2011-12-31
NCT00567983 Topical Cyclosporine and Disease Progression https://ClinicalTrials.gov/show/NCT00567983 Completed Innovative Medical 2008-09-30
NCT00800098 Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee https://ClinicalTrials.gov/show/NCT00800098 Completed Stanford University 2009-09-30
NCT00507221 Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression https://ClinicalTrials.gov/show/NCT00507221 Completed University of Washington 2011-07-31
NCT00503685 Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy https://ClinicalTrials.gov/show/NCT00503685 Completed Eli Lilly and Company 2009-03-31
NCT00499876 The Effect of Malaria on Disease Progression of HIV/AIDS https://ClinicalTrials.gov/show/NCT00499876 Completed London School of Hygiene and Tropical Medicine 2008-10-31
NCT00456365 Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD) https://ClinicalTrials.gov/show/NCT00456365 Completed University of Colorado, Denver 2012-10-31
NCT00415259 Effects of Shoes Insoles on Symptoms and Disease Progression in Knee Osteoarthritis https://ClinicalTrials.gov/show/NCT00415259 Completed University of Melbourne 2008-12-31
NCT00404170 Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease https://ClinicalTrials.gov/show/NCT00404170 Completed Institute for Neurodegenerative Disorders 2014-07-31
NCT00383669 A Trial of Vitamins and HAART in HIV Disease Progression https://ClinicalTrials.gov/show/NCT00383669 Completed Harvard School of Public Health 2009-10-31
NCT00335049 Study of Theories About Myopia Progression (STAMP) https://ClinicalTrials.gov/show/NCT00335049 Completed Ohio State University 2010-07-31
NCT00221845 Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients https://ClinicalTrials.gov/show/NCT00221845 Completed Heidelberg University 2007-07-31
NCT00214487 Bifocal Soft Contact Lenses and Their Effect on Myopia Progression in Children and Adolescents. https://ClinicalTrials.gov/show/NCT00214487 Completed Aller, Thomas A., OD 2006-03-31
NCT00063726 A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039 https://ClinicalTrials.gov/show/NCT00063726 Completed Millennium Pharmaceuticals, Inc. 2005-05-31
NCT00006144 A Study of HIV-Disease Development in Aging https://ClinicalTrials.gov/show/NCT00006144 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001068 A Study of Disease Progression and Anti-HIV Treatments https://ClinicalTrials.gov/show/NCT00001068 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000653 A Trial of Two Doses of 2’,3’-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT https://ClinicalTrials.gov/show/NCT00000653 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT00091871 A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression https://ClinicalTrials.gov/show/NCT00091871 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT04462068 ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients https://ClinicalTrials.gov/show/NCT04462068 Recruiting University of Aarhus 2023-11-30
NCT04358107 Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC) https://ClinicalTrials.gov/show/NCT04358107 Enrolling by invitation National Institutes of Health Clinical Center (CC) 2022-12-31
NCT03401307 Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis https://ClinicalTrials.gov/show/NCT03401307 Active, not recruiting University of Southern Denmark 2020-07-31
NCT03362658 Novel MRI Biomarkers for Monitoring Disease Progression in ALS https://ClinicalTrials.gov/show/NCT03362658 Recruiting University of Alberta 2020-12-31
NCT04105153 Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC https://ClinicalTrials.gov/show/NCT04105153 Enrolling by invitation Thoraxklinik-Heidelberg gGmbH 2020-06-30
NCT03300739 Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients https://ClinicalTrials.gov/show/NCT03300739 Recruiting Massachusetts General Hospital 2018-12-31
NCT03278899 A Study to Prospectively Assess Disease Progression in Male Children With X-ALD https://ClinicalTrials.gov/show/NCT03278899 Recruiting NeuroVia, Inc. 2021-06-01
NCT03126201 Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis https://ClinicalTrials.gov/show/NCT03126201 Completed Istanbul University 2017-09-30
NCT03121768 A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) https://ClinicalTrials.gov/show/NCT03121768 Recruiting Mansoura University 2019-12-01
NCT03020394 Respiratory Support in Severe Chronic Obstructive Pulmonary Disease Exacerbation https://ClinicalTrials.gov/show/NCT03020394 Recruiting China-Japan Friendship Hospital 2020-12-31
NCT02782013 Study of Progression of Community Acquired Pneumonia in the Hospital https://ClinicalTrials.gov/show/NCT02782013 Recruiting Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps 2019-12-31
NCT02742064 Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression https://ClinicalTrials.gov/show/NCT02742064 Completed Cogito Health Inc 2017-12-31
NCT02640339 Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease https://ClinicalTrials.gov/show/NCT02640339 Recruiting NYU Langone Health 2020-02-29
NCT02608515 A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease https://ClinicalTrials.gov/show/NCT02608515 Completed Genesis Pharma S.A. 2016-09-30
NCT03394521 Progression of Disease in Patients Newly Diagnosed With Glaucoma and Glaucoma Suspects Participating in the GATE Study https://ClinicalTrials.gov/show/NCT03394521 Completed University of Aberdeen 2016-08-31
NCT02549703 Mitochondrial Dysfunction and Disease Progression https://ClinicalTrials.gov/show/NCT02549703 Completed Icahn School of Medicine at Mount Sinai 2018-09-27
NCT02547740 Macular Damage in Early Glaucoma and Progression https://ClinicalTrials.gov/show/NCT02547740 Recruiting Columbia University 2020-10-31
NCT02439372 Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02439372 Completed Asan Medical Center 2016-06-30
NCT02437474 Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot Study https://ClinicalTrials.gov/show/NCT02437474 Completed Verein Essen und Krebs 2016-12-31
NCT02363595 Genomic Predictors of Papillary Microcarcinoma Disease Progression https://ClinicalTrials.gov/show/NCT02363595 Recruiting Memorial Sloan Kettering Cancer Center 2021-12-31
NCT02352220 Determinants of Onset and Progression of COPD in Young Adults https://ClinicalTrials.gov/show/NCT02352220 Active, not recruiting Hospital Son Espases 2020-12-31
NCT02203929 Preoperative Progression of Macular Holes https://ClinicalTrials.gov/show/NCT02203929 Completed Glostrup University Hospital, Copenhagen 2015-03-31
NCT02159612 1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy https://ClinicalTrials.gov/show/NCT02159612 Completed Rigshospitalet, Denmark 2015-03-31
NCT02153684 Canadian Cohort on the Origin and Progression of Airway Disease: Physiology Platform https://ClinicalTrials.gov/show/NCT02153684 Recruiting Queen’s University 2020-08-31
NCT02137707 Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya https://ClinicalTrials.gov/show/NCT02137707 Completed McGill University 2017-11-30
NCT02044029 Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers. https://ClinicalTrials.gov/show/NCT02044029 Completed Hoffmann-La Roche 2015-07-31
NCT04204876 Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course https://ClinicalTrials.gov/show/NCT04204876 Recruiting University Hospital, Basel, Switzerland 2023-02-01
NCT02011932 Prospective Observational Study of Disease Progression in Chronic Hepatitis C https://ClinicalTrials.gov/show/NCT02011932 Active, not recruiting Beijing YouAn Hospital 2011-06-30
NCT01923103 Natural Disease Progress of Dupuytren Disease https://ClinicalTrials.gov/show/NCT01923103 Active, not recruiting University Medical Center Groningen 2022-07-31
NCT01920100 Resource Use and Disease Course in Dementia (REDIC) https://ClinicalTrials.gov/show/NCT01920100 Active, not recruiting Sykehuset Innlandet HF 2015-01-31
NCT01742819 Advanced Glaucoma Progression Study https://ClinicalTrials.gov/show/NCT01742819 Active, not recruiting University of California, Los Angeles 2020-12-31
NCT01651078 Laser Ablation After Stereotactic Radiosurgery https://ClinicalTrials.gov/show/NCT01651078 Completed Monteris Medical 2016-08-31
NCT01515709 Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01515709 Completed Royal Brompton & Harefield NHS Foundation Trust 2013-09-30
NCT01507415 Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD? https://ClinicalTrials.gov/show/NCT01507415 Completed Royal Brompton & Harefield NHS Foundation Trust 2013-02-28
NCT01489839 Biomarkers of Periodontal Disease Progression https://ClinicalTrials.gov/show/NCT01489839 Completed The Forsyth Institute 2016-06-30
NCT01431911 Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation https://ClinicalTrials.gov/show/NCT01431911 Completed GlaxoSmithKline 2010-12-31
NCT01400971 An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes https://ClinicalTrials.gov/show/NCT01400971 Completed Eli Lilly and Company 2015-09-30
NCT01362621 Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma https://ClinicalTrials.gov/show/NCT01362621 Completed Novartis 2010-02-28
NCT01348035 Efficacy Study of Water Drinking on PKD Progression. https://ClinicalTrials.gov/show/NCT01348035 Completed Kyorin University 2012-11-30
NCT01337661 A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations https://ClinicalTrials.gov/show/NCT01337661 Completed MedImmune LLC 2012-01-31
NCT04426253 Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19 https://ClinicalTrials.gov/show/NCT04426253 Active, not recruiting Szeged University 2020-12-31
NCT04343456 Salvage Surgery for Patients With Metastatic GIST With Rego https://ClinicalTrials.gov/show/NCT04343456 Completed Chang Gung Memorial Hospital 2019-12-31
NCT04228172 Genotypic Influences on Network Progression in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04228172 Recruiting Northwell Health 2023-01-01
NCT04052256 The Heartflow Coronary Disease Progression Evaluation Study https://ClinicalTrials.gov/show/NCT04052256 Recruiting Erasmus Medical Center 2021-10-31
NCT04049877 Retrospective and Prospective Disease Progression and Quality of Life in XLH https://ClinicalTrials.gov/show/NCT04049877 Recruiting Medialis Ltd. 2020-07-31
NCT04021394 Influence of EMT on CTCs and Disease Progression in Prostate Cancer https://ClinicalTrials.gov/show/NCT04021394 Recruiting Lawson Health Research Institute 2020-09-30
NCT03873935 Vitamin D in Periodontal and Cardiovascular Disease Progression https://ClinicalTrials.gov/show/NCT03873935 Completed University of Messina 2018-01-05
NCT03833960 SLNB After Neoadjuvant Treatment in Node Positive Patients https://ClinicalTrials.gov/show/NCT03833960 Completed Clinical Hospital Center Rijeka 2019-05-31
NCT03799263 A Six Minute Walking Test Based Index as an Outcome Predictor in COPD Subjects. (Chronic Obstructive Pulmonary Disease) https://ClinicalTrials.gov/show/NCT03799263 Recruiting Maugeri Foundation 2020-07-30
NCT03788369 Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization https://ClinicalTrials.gov/show/NCT03788369 Recruiting Asan Medical Center 2030-06-30
NCT03723629 Progression of Untreated Pulmonary Ground Glass Opacity https://ClinicalTrials.gov/show/NCT03723629 Recruiting Shanghai Zhongshan Hospital 2022-06-30
NCT03635541 Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03635541 Recruiting Beijing Friendship Hospital 2021-02-28
NCT03632473 Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis https://ClinicalTrials.gov/show/NCT03632473 Recruiting University Hospital, Basel, Switzerland 2022-07-31
NCT03591562 Imaging Progression of Chronic Obstructive Pulmonary Disease Using MRI and CT (MR-COPDII) https://ClinicalTrials.gov/show/NCT03591562 Enrolling by invitation University Hospital Heidelberg 2020-09-30
NCT03577327 The Gut and Skin Microbiome in Vitiligo Disease Progression https://ClinicalTrials.gov/show/NCT03577327 Recruiting Northwestern University 2021-06-30
NCT03541863 Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients https://ClinicalTrials.gov/show/NCT03541863 Completed Fudan University 2018-12-15
NCT03540381 Relation Among HDL Functionality, Neoatherosclerosis and Target Lesion Revascularization https://ClinicalTrials.gov/show/NCT03540381 Completed Kobe University 2017-07-31
NCT03538262 Assessing Tele-Health Outcomes in Multiyear Extensions of PD Trials https://ClinicalTrials.gov/show/NCT03538262 Enrolling by invitation Massachusetts General Hospital 2022-04-30
NCT03536169 Utilization of Anti-reflux Treatment and Course of Illness Leading to Reoperation https://ClinicalTrials.gov/show/NCT03536169 Active, not recruiting University of Southern Denmark 2020-06-01
NCT03533959 To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy https://ClinicalTrials.gov/show/NCT03533959 Recruiting Kobe University 2020-12-31
NCT03525665 Study on the Role of FDG-PET in Patients With FL at Time of Relapse/Progression https://ClinicalTrials.gov/show/NCT03525665 Completed Fondazione Italiana Linfomi ONLUS 2019-12-30
NCT03455439 Risk Factors of Outcomes Associated With Disease Progression in Patients With Atrial Fibrillation and Heart Failure (HF) Who Are Receiving a Direct Oral Anticoagulant (Rivaroxaban) https://ClinicalTrials.gov/show/NCT03455439 Active, not recruiting Bayer 2021-07-31
NCT03431896 Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis https://ClinicalTrials.gov/show/NCT03431896 Recruiting The Cleveland Clinic 2024-02-15
NCT03411317 Aortic Stenosis: Determinants of Progression, Severity and Left Ventricular Remodeling https://ClinicalTrials.gov/show/NCT03411317 Recruiting University Hospital, Rouen 2023-12-31
NCT01262716 A Novel Therapy for the Treatment of Chest Wall Progression of Breast Cancer https://ClinicalTrials.gov/show/NCT01262716 Completed Rogers Sciences Inc. 2011-08-31
NCT01241058 Registry of Pediatric Patients Diagnosed With Crohn’s Disease in Belgium https://ClinicalTrials.gov/show/NCT01241058 Completed Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition 2015-04-30
NCT01145911 The Study of Ocular Hemodynamics With Glaucoma Progression https://ClinicalTrials.gov/show/NCT01145911 Completed Indiana University 2014-07-03
NCT00914225 Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya https://ClinicalTrials.gov/show/NCT00914225 Completed University of Washington 2011-12-31
NCT00888030 P-cresol: Correlation With Glomerular Filtration Rate and Outcome in Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT00888030 Completed Chang Gung Memorial Hospital 2011-12-31
NCT00876577 VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis https://ClinicalTrials.gov/show/NCT00876577 Completed Bayer 2011-03-31
NCT00873873 Progression of Airway Obstruction in Childhood Asthma https://ClinicalTrials.gov/show/NCT00873873 Completed National Jewish Health 2011-06-30
NCT01442896 STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk https://ClinicalTrials.gov/show/NCT01442896 Completed University of California, San Diego 2015-01-27
NCT02131428 Depression and Heart Failure Disease Progression https://ClinicalTrials.gov/show/NCT02131428 Active, not recruiting Duke University 2020-07-31
NCT03718481 Perceptions of the Annual Review of Competence Progression (ARCP) in Surgical Training in the UK and Ireland https://ClinicalTrials.gov/show/NCT03718481 Completed University College Hospital Galway 2018-03-31
NCT00790543 Risk Stratification of Rapid Disease Progression in Children With Crohn’s Disease https://ClinicalTrials.gov/show/NCT00790543 Active, not recruiting Emory University 2019-12-31
NCT00606918 Validation of a New Device to Measure Neuromuscular Disease Progression https://ClinicalTrials.gov/show/NCT00606918 Completed Massachusetts General Hospital 2010-09-30
NCT00505297 A Longitudinal Study of Osteoarthritis (OA) Disease Progression Measured by MRI, dGEMRIC, and Radiography https://ClinicalTrials.gov/show/NCT00505297 Completed University of California, San Francisco NA
NCT00373841 Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) https://ClinicalTrials.gov/show/NCT00373841 Recruiting University of Pittsburgh 2025-07-31
NCT00339261 Disease Progression and Activity in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00339261 Completed National Institutes of Health Clinical Center (CC) NA
NCT00107029 Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth https://ClinicalTrials.gov/show/NCT00107029 Completed University of North Carolina, Chapel Hill 2005-09-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT01947127 Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency Department https://ClinicalTrials.gov/show/NCT01947127 Completed Chulalongkorn University 2014-11-30
NCT01865877 Motor, Non-motor and Genetic Determinants of Progression in Parkinson’s Disease: A Mexican Multicenter Cohort Study https://ClinicalTrials.gov/show/NCT01865877 Completed El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez 2016-08-31
NCT03349385 Registry of Secondary Revascularization https://ClinicalTrials.gov/show/NCT03349385 Active, not recruiting Hospital San Carlos, Madrid 2021-01-15
NCT04062279 Predictors of Parkinson’s Disease Progression https://ClinicalTrials.gov/show/NCT04062279 Recruiting Ain Shams University 2022-04-30
NCT03890822 Coronary Artery Disease Progression in Patients With Acute Coronary Syndromes and Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03890822 Recruiting Humanitas Hospital, Italy 2022-03-25
NCT03509779 Pronostic and Predictive Value of EMT in Localized Lung Cancer https://ClinicalTrials.gov/show/NCT03509779 Recruiting European Georges Pompidou Hospital 2018-03-31
NCT03474692 Virta Health Registry https://ClinicalTrials.gov/show/NCT03474692 Active, not recruiting Virta Health 2039-10-31